Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06564142
What this trial is testing

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy
Alpine Immune Sciences Inc, A Subsidiary of Vertex 605
Large-scale testing (Phase 3)Ended earlyNCT04181762
What this trial is testing

Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 275
Not applicableNot Yet RecruitingNCT07431931
What this trial is testing

Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria

Who this might be right for
Referral and ConsultationGlomerulonephritisHematuria+2 more
Geisinger Clinic 1,200
Testing effectiveness (Phase 2)Study completedNCT03804359
What this trial is testing

Personalized Medicine for Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Centre Hospitalier Universitaire de Nice 68
Early research (Phase 1)Study completedNCT04278729
What this trial is testing

A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeMembranous Nephropathy
University of North Carolina, Chapel Hill 22
Early research (Phase 1)Study completedNCT05398510
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject

Who this might be right for
IgA Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd 61
Early research (Phase 1)Looking for participantsNCT06943937
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis (LN)Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd. 36
Large-scale testing (Phase 3)Active Not RecruitingNCT03418779
What this trial is testing

Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD

Who this might be right for
IgA Nephropathy at High Risk of Developing ESRD
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 60
Testing effectiveness (Phase 2)Looking for participantsNCT05775042
What this trial is testing

Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy

Who this might be right for
IgA Nephropathy
Keymed Biosciences Co.Ltd 70
Not applicableUnknownNCT00868270
What this trial is testing

Urinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After Pyelonephritis

Who this might be right for
Kidney Scarring Post-Febrile UTI
Hillel Yaffe Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT03385564
What this trial is testing

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Boehringer Ingelheim 69
Very early researchLooking for participantsNCT06497387
What this trial is testing

Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease

Who this might be right for
Lupus NephritisIgG4-related Disease
Tongji Hospital 30
Early research (Phase 1)Enrolling By InvitationNCT06375993
What this trial is testing

Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease

Who this might be right for
Lupus NephritisAutoimmune DiseasesSystemic Sclerosis (SSc)+4 more
Adicet Therapeutics 180
Early research (Phase 1)Not Yet RecruitingNCT07445906
What this trial is testing

RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment

Who this might be right for
Renal ImpairmentsIgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT04183101
What this trial is testing

Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

Who this might be right for
C3 GlomerulopathyMembranoproliferative GlomerulonephritisComplement Abnormality+2 more
Region Skane 30
Large-scale testing (Phase 3)Looking for participantsNCT06935357
What this trial is testing

Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Biogen 454
Not applicableStudy completedNCT03063281
What this trial is testing

Anti-ficolin-2 Autoantibodies in Lupus Nephritis

Who this might be right for
Lupus Erythematosus, Systemic
University Hospital, Grenoble 213
Early research (Phase 1)Study completedNCT00345137
What this trial is testing

Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis

Who this might be right for
ADPKDGlomerulonephritis
Regional Hospital Holstebro 75
Not applicableWithdrawnNCT04369495
What this trial is testing

BAFF Levels and Lupus Nephritis (LN)

Who this might be right for
Lupus Nephritis
Universidad de Antioquia
Large-scale testing (Phase 3)Active Not RecruitingNCT03762850
What this trial is testing

The Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Travere Therapeutics, Inc. 406
Next Page